Guardian Capital LP on March 4 debuted its Guardian i 3 Global Dividend Premium Yield Fund and ETF (TSX: GIDY). The invests primarily in global dividend-paying securities and uses a dynamic ...

We also observed large increases in downstream anti-cancer immune cytokines, including interferon-gamma, our FDA-endorsed potency assay and TGF-alpha ... with extensive global clinical development ...

Obsidian Therapeutics, a specialist in tumour-infiltrating lymphocyte (TIL) cell therapies, has raised $160.5 million in a third-round financing round that will be used to fund its clinical ...

The fund seeks to benefit from the inherent volatility in the natural resource sector, using low net and gross positioning to achieve superior risk adjusted returns with low correlation to major asset ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Tribeca Global Natural Resources Limited (TGF). However, you won't necessarily see their names ...

During this time of uncertainty about the future role of the world’s biggest donor, the Global Fund stands as a beacon of hope. Since the beginning of the millennium, the Geneva-based multilateral ...

Davis Global Fund posted a strong return of +22.70% in 2024, substantially outperforming its MSCI ACWI (All Country World Index) benchmark. We believe China may be starting to emerge from its long ...

While global TGF-β inhibition strategies have shown limited success due to systemic toxicity, a more targeted modulation approach may be key to achieving sustained anti-tumor activity.

Cash levels are at 3.5% of assets under management, the lowest ratio since 2010, according to Bank of America's latest survey of global fund managers. Investors are "long stocks, short everything ...

Overall, Vanguard Total World Stock ETF has lived up to its billing. Low-fee, well-diversified index-tracking funds typically ...